These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pragsam AK; Kumar DT; Doss CGP; Iyadurai R; Satyendra S; Rodrigues C; Joshi S; Roy I; Chaudhuri BN; Chitnis DS; Tapan D; Veeraraghavan B Indian J Med Microbiol; 2018; 36(1):127-130. PubMed ID: 29735843 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process]. Semykin SIu; Postnikov SS; Polikarpova SV; Perederko LV Antibiot Khimioter; 2003; 48(12):18-21. PubMed ID: 15176099 [TBL] [Abstract][Full Text] [Related]
6. Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa. Cai Y; Yang D; Wang J; Wang R Diagn Microbiol Infect Dis; 2018 Jun; 91(2):186-190. PubMed ID: 29486972 [TBL] [Abstract][Full Text] [Related]
7. Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery. Riku S; Suzuki S; Jinno Y; Tanaka A; Ishii H; Murohara T Can J Cardiol; 2020 Jun; 36(6):967.e1-967.e3. PubMed ID: 32407676 [TBL] [Abstract][Full Text] [Related]
8. Haemophilus influenzae pericarditis successfully treated by catheter drainage. Houghton JL; Becherer PR South Med J; 1987 Jun; 80(6):766-8. PubMed ID: 3495887 [TBL] [Abstract][Full Text] [Related]
10. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia. Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577 [TBL] [Abstract][Full Text] [Related]
12. Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice. Chandrasekar PH; Sluchak JA; Kruse JA Antimicrob Agents Chemother; 1993 Sep; 37(9):1927-30. PubMed ID: 8239607 [TBL] [Abstract][Full Text] [Related]
16. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections. Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198 [TBL] [Abstract][Full Text] [Related]
17. Pacemaker pocket infection associated with septicemia caused by Pseudomonas aeruginosa. Nandhakumar B; Menon T; Ravishankar G; Shanmugasundaram S Int J Infect Dis; 2008 Jan; 12(1):107-8. PubMed ID: 17587621 [No Abstract] [Full Text] [Related]
18. [Laboratory and clinical study on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa]. Hayashi I; Sakurai M; Ichiki M; Sekine I; Nakayama K; Shiotani J; Yoshida T; Niida M; Ogawa M; Koumoto A Jpn J Antibiot; 1994 Jan; 47(1):29-39. PubMed ID: 8114271 [TBL] [Abstract][Full Text] [Related]
19. Hybrid revascularisation in multivessel coronary artery disease: could a combination of CABG and PCI be the best option in selected patients? Wrigley BJ; Dubey G; Spyt T; Gershlick AH EuroIntervention; 2013 Mar; 8(11):1335-41. PubMed ID: 23538160 [No Abstract] [Full Text] [Related]
20. Purulent pericarditis complicating coronary artery bypass. Rotstein C; Holley HP South Med J; 1982 Apr; 75(4):509-10. PubMed ID: 6978539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]